Share this article on:

Evaluating Human Papillomavirus Vaccination Programs

Donovan, Basil MD*†; Guy, Rebecca J. PhD*

Sexually Transmitted Diseases: April 2013 - Volume 40 - Issue 4 - p 290–291
doi: 10.1097/OLQ.0b013e318282d69b
Editorial

From the *The Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia; and †Sydney Sexual Health Centre, Sydney Hospital, Sydney NSW 2000, Australia.

Conflicts of interest: B.D. and R.J.G. receive research funding from CSL Biotherapies. B.D. has received speaker’s honoraria from Merck and Sanofi-PasteurMSD.

Correspondence: Basil Donovan, MD, The Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia. E-mail: bdonovan@kirby.unsw.edu.au.

Received for publication November 5, 2012, and accepted December 12, 2012.

© Copyright 2013 American Sexually Transmitted Diseases Association